Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

De Minicis S, Kisseleva T, Francis H, Baroni GS, Benedetti A, Brenner D, Alvaro D, Alpini G, Marzioni M.

Dig Liver Dis. 2013 Jun;45(6):450-9. doi: 10.1016/j.dld.2012.10.008. Epub 2012 Nov 22. Review.

2.

Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model.

Heindryckx F, Bogaerts E, Coulon SH, Devlies H, Geerts AM, Libbrecht L, Stassen JM, Carmeliet P, Colle IO, Van Vlierberghe HR.

Eur J Gastroenterol Hepatol. 2012 Sep;24(9):1020-32. doi: 10.1097/MEG.0b013e3283554219.

PMID:
22772092
3.
4.

Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice.

Heindryckx F, Kuchnio A, Casteleyn C, Coulon S, Olievier K, Colle I, Geerts A, Libbrecht L, Carmeliet P, Van Vlierberghe H.

J Hepatol. 2012 Jul;57(1):61-8. doi: 10.1016/j.jhep.2012.02.021. Epub 2012 Mar 13.

PMID:
22420978
5.

A ΔRaf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures.

He S, Krens SG, Zhan H, Gong Z, Hogendoorn PC, Spaink HP, Snaar-Jagalska BE.

J Pathol. 2011 Sep;225(1):19-28. doi: 10.1002/path.2936. Epub 2011 Jul 8.

PMID:
21744342
6.

[Evolutive characters of oval cells in experimental hepatocarcinogenesis].

Chen QR, Xiang J, Liao B, Liu QB, Che LH, Xue L, Zhao GQ.

Ai Zheng. 2007 Jul;26(7):719-23. Chinese.

PMID:
17626747
7.

Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.

Liu B, Hervé J, Bioulac-Sage P, Valogne Y, Roux J, Yilmaz F, Boisgard R, Guettier C, Calès P, Tavitian B, Samuel D, Clerc J, Bréchot C, Faivre J.

Gastroenterology. 2007 Apr;132(4):1495-503. Epub 2007 Jan 26.

PMID:
17408651
8.

Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.

Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY.

Hepatology. 2012 Jan;55(1):108-20. doi: 10.1002/hep.24675. Epub 2011 Dec 6.

PMID:
21932402
9.

Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.

Gil-Benso R, Martinez-Lorente A, Pellin-Perez A, Navarro-Fos S, Gregori-Romero MA, Carda C, Callaghan R, Peydro-Olaya A, Llombart-Bosch A.

In Vitro Cell Dev Biol Anim. 2001 Jan;37(1):17-25.

PMID:
11249201
10.

Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation.

Thamavit W, Pairojkul C, Tiwawech D, Itoh M, Shirai T, Ito N.

Carcinogenesis. 1993 Nov;14(11):2415-7.

PMID:
8242874
11.

A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.

Wakasa T, Wakasa K, Shutou T, Hai S, Kubo S, Hirohashi K, Umeshita K, Monden M.

Hepatogastroenterology. 2007 Mar;54(74):508-13.

PMID:
17523309
12.

Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.

Morris SM, Baek JY, Koszarek A, Kanngurn S, Knoblaugh SE, Grady WM.

Hepatology. 2012 Jan;55(1):121-31. doi: 10.1002/hep.24653. Epub 2011 Dec 6.

13.

Mouse models of hepatocellular carcinoma.

Fausto N, Campbell JS.

Semin Liver Dis. 2010 Feb;30(1):87-98. doi: 10.1055/s-0030-1247135. Epub 2010 Feb 19. Review.

PMID:
20175036
14.
15.

[Combined hepato-cholangiocarcinoma. Case presentation and literature review].

Salas AA, González AL, Goepfert RH.

Rev Gastroenterol Mex. 2006 Oct-Dec;71(4):483-6. Spanish.

PMID:
17542282
16.

[A case of combined hepatocellular-cholangiocarcinoma with sarcomatous transformation and second primary colon cancer].

Kim JH, Lee YG, Lee J, Jung CK, Kim HT, Kang H, Kho KH, Hong SP, Hwang SG, Park PW, Rim GS.

Korean J Hepatol. 2004 Jun;10(2):142-7. Korean.

17.

Transplantation for hepatocellular carcinoma and cholangiocarcinoma.

Campos BD, Botha JF.

J Natl Compr Canc Netw. 2009 Apr;7(4):409-16; quiz 417. Review.

PMID:
19406041
18.

Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma.

You HL, Weng SW, Li SH, Wei YC, Sheu JJ, Chen CM, Huang WT.

Exp Mol Pathol. 2012 Jun;92(3):281-6. doi: 10.1016/j.yexmp.2012.01.009. Epub 2012 Feb 17.

PMID:
22366251
19.

Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.

Körner M, Hayes GM, Rehmann R, Zimmermann A, Scholz A, Wiedenmann B, Miller LJ, Reubi JC.

J Hepatol. 2006 Dec;45(6):825-35. Epub 2006 Jul 28.

PMID:
16935383
20.

Supplemental Content

Support Center